- A €1.5 billion refinancing plan to strengthen its
financial structure well under way, including the execution of the
capital increase to be approved by the Annual shareholder meeting
on the 10th of June
- A solid outlook for 2023-2026, following the full execution
of the refinancing plan:
- Average annual organic growth of around 5%
- EBITDA margin, pre IFRS 16, expected to rise by 100 to 150
basis points by 2026
- Financial leverage of less than 3x and LTV of 55% by the end
of 2025
- Reaffirmed ESG commitments
Regulatory News:
Clariane (Paris:CLARI) (CLARIA.PA - ISIN FR0010386334) is
holding an information meeting today from 2pm to 6pm at which the
Group will present its strategic plan and outlook for the period
2023-2026.
This meeting will be held following the announcement on Friday
17 May of plans to increase the company's capital by a total amount
of c.€ 328 million, as part of the reinforcement of its financial
structure, and the planned investment of HLD Europe as a new major
shareholder, supporting the implementation of its "At your side"
corporate project and its commitments as a purpose-driven
company.
Sophie Boissard, Director and Chief Executive Officer of the
Group, said:
“Since 2020, Clariane has had to face a series of unprecedented
challenges, with the Covid-19 pandemic, the sectoral turbulence
resulting from the Orpea affair, the sharp rise in inflation and
the tightening of credit conditions.
Thanks to the unwavering commitment of our employees and the
support of our stakeholders, our company has been able to
demonstrate its resilience and reinvent itself, in line with its
values and mission: "to take care for each person’s humanity in
times of fragility".
Once our annual shareholder meeting will have approved the
modalities of the capital increase included in our refinancing
plan, we will be turning a new page, backed by the support of our
shareholders and the professionalism of our 60,000 employees, who
are more committed than ever to constantly improving the quality
and relevance of the care and services that our patients, residents
and their families expect of us”
***
In response to the public health challenges posed by an ageing
population and an increase in chronic illnesses, Clariane has
developed a range of diversified and complementary forms of support
and care in its various regions, organised around the following
three segments:
- Long-Term Care;
- Specialty Care;
- Community Care.
As part of its “At your side” corporate project, Clariane
is promoting the development of personalised care solutions,
grounded in local ecosystems and in the needs of vulnerable people
and their carers.
It is developing a common skills base to all its activities,
including the use of rigorous medical expertise, consistent quality
standards, a policy of skills development and promotion through
training leading to qualifications, and the gradual digitalisation
of key processes.
In line with its decision to become a purpose-driven company
with high levels of accountability, the company's governance
includes its stakeholders building trust and regularly measures its
non-financial performance.
Following the tightening of credit conditions and sectoral
turbulence, Clariane launched a plan on 14 November to
strengthen its financial structure.
Implementation of the various aspects of this plan is well under
way, as outlined in the press release published by the Group on the
17th of May, including the execution of the capital increase to be
approved by the annual shareholder meeting on the 10th of June.
Confirming its objectives for 2024, and building on the progress
made with the plan to strengthen its financial structure, the Group
today announces its main outlook for the period
2023-2026:
- Average annual organic growth (CAGR) in sales of around
+5%, driven in particular by a gradual and steady increase in
occupancy rates and activity levels in Specialized Care, especially
in outpatient care, and by the ongoing catch-up of tariffs,
particularly in Germany;
- An improvement of 100 to 150 basis points in its EBITDA
margin, pre-IFRS16, driven mainly by revenue growth and
targeted improvements in its central cost structures, rent and
energy costs;
- Opco leverage of less than 3.0x by the end of 2025, with
an LTV of 55%.
At the same time, the Group has set the following ESG targets
for 2026:
- 7,000 employees enrolled in a qualifying path through the
Clariane University
- NPS maintained above 40
- Lost-time injury frequency rate down to 29
- Implementing the SBTi commitments on the carbon trajectory
The presentation associated with this information meeting is
available on the clariane.com website.
The meeting will also be broadcast live on the Clariane website
and be viewed here
Disclaimer:
This press release does not constitute, and shall not be deemed
to constitute, an offer to the public or an offer to purchase or
the solicitation of public interest in a transaction by way of
public offer, nor shall there be any sale of securities in any
state or jurisdiction in which such offer, solicitation or sale
would be unlawful absent registration or approval under the
securities laws of such state or jurisdiction. The distribution of
this document may be subject to specific restrictions in certain
countries. Persons in possession of this document are required to
inform themselves of and to observe any such local restrictions.
The shares of Clariane S.E. (the “Company”) (and any rights to
subscribe for shares of the Company) have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the
“U.S. Securities Act”), and may not be offered or sold within the
United States absent registration or an applicable exemption from,
or in a transaction not subject to, the registration requirements
of the U.S. Securities.
A prospectus relating to the capital increase will be submitted
by Clariane S.E. to the Autorité des marchés financiers for
approval before the effective launch of the capital increase.
This document contains forward-looking statements that involve
risks and uncertainties, including information incorporated by
reference, regarding the Group’s expected growth and profitability
in the future that may significantly impact the expected
performance indicated in the forward-looking statements. These
risks and uncertainties relate to factors that the Company can
neither control nor accurately estimate, such as future market
conditions. Any forward-looking statements made in this document
express expectations for the future and should be regarded as such.
Actual events or results may differ from those described in this
document due to a number of risks and uncertainties that are
described in Chapter 2 of the 2023 Universal Registration Document
filed with the Autorité des Marchés Financiers (AMF) on April 30,
2023 under the registration number D.24-0380, which is available on
the Company's website, on the website of the French financial
markets authority, AMF (www.amf-france.org). All forward-looking
statements included in this document speak only as of the date of
this press release. Clariane S.E. undertakes no obligation and
assumes no responsibility to update the information contained
herein beyond what is required by applicable regulations.
In this press release, unless otherwise indicated, all changes
are expressed on an annual basis (2024/2023), and at constant scope
of consolidation and exchange rates.
The main alternative performance indicators (APIs), such as
EBITDA, EBIT, net debt and financial leverage, are defined in the
Universal Registration Document available on the company's website
at www.clariane.com.
About Clariane
Clariane is the leading European community for care in times of
vulnerability. It has operations in six countries: Belgium, France,
Germany, Italy, the Netherlands, and Spain.
Relying on their diverse expertise, each year the Group’s 60,000
professionals provide services to over 800,000 patients and
residents in three main areas of activity: long-term care nursing
home (Korian, Seniors Residencias, Berkley, etc.), specialized care
facilities and services (Inicea, Ita, Grupo 5, Lebenswert, etc.),
and alternative living solutions (Petits-fils, Ages et Vie,
etc.).
In June 2023, Clariane became a purpose-driven company and added
to its bylaws a new corporate purpose, common to all its
activities: “To take care of each person’s humanity in times of
vulnerability”.
Clariane has been listed on Euronext Paris since November
2006, In compartment B
Euronext ticker: CLARI - ISIN: FR0010386334
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240520488615/en/
Investors
Stéphane Bisseuil Investor Relations Director +33
(0) 6 58 60 68 69 stephane.bisseuil@clariane.com
Press
Matthieu Desplats Press Relations Director 06 58
09 01 61 matthieu.desplats@clariane.com
Julie Mary Head of press relations 06 59 72 50 69
julie.mary@clariane.com
Florian Bachelet Head of press relations 06 79 86 78 23
florian.bachelet@clariane.com
Clariane (EU:CLARI)
Historical Stock Chart
From Jul 2024 to Aug 2024
Clariane (EU:CLARI)
Historical Stock Chart
From Aug 2023 to Aug 2024